Protagonist Therapeutics Inc buy Barclays PLC
Start price
07.11.25
/
50%
€69.00
Target price
07.11.26
€76.27
Performance (%)
73.91%
Price
05.08.26
€120.00
Summary
This prediction is currently active. With a performance of 73.91% the BUY prediction by Barclays_PLC is a big success. This prediction currently runs until 07.11.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | 2.564% | 2.564% |
| iShares Core DAX® | 3.153% | 1.504% |
| iShares Nasdaq 100 | 7.431% | -1.584% |
| iShares Nikkei 225® | 8.571% | -4.324% |
| iShares S&P 500 | 4.578% | 1.920% |
Comments by Barclays_PLC for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its price target raised by analysts at Barclays PLC from $72.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Barclays_PLC for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€88.00
19.03.26
19.03.26
€103.58
19.03.27
19.03.27
36.36%
05.08.26
05.08.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€77.00
26.02.26
26.02.26
€95.61
26.02.27
26.02.27
55.84%
05.08.26
05.08.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€53.00
17.09.25
17.09.25
€60.73
17.09.26
17.09.26
126.42%
05.08.26
05.08.26